Stacy L. Taylor - 17 Jun 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
SVP and General Counsel
Signature
/s/ Stacy L. Taylor by Eric Billings as attorney-in-fact
Issuer symbol
ADPT
Transactions as of
17 Jun 2021
Net transactions value
-$103,985
Form type
4
Filing time
21 Jun 2021, 20:00:50 UTC
Next filing
01 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Options Exercise $8,120 +1,041 +6.9% $7.80 16,077 17 Jun 2021 Direct F1
transaction ADPT Common Stock Options Exercise $11,600 +1,771 +11% $6.55 17,848 17 Jun 2021 Direct F1
transaction ADPT Common Stock Options Exercise $42,935 +1,354 +7.6% $31.71* 19,202 17 Jun 2021 Direct F1
transaction ADPT Common Stock Sale $166,640 -4,166 -22% $40.00* 15,036 17 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -1,041 -4.2% $0.000000 23,959 17 Jun 2021 Common Stock 1,041 $7.80 Direct F1, F2
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -1,771 -9.1% $0.000000 17,709 17 Jun 2021 Common Stock 1,771 $6.55 Direct F1, F3
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -1,354 -2.9% $0.000000 44,688 17 Jun 2021 Common Stock 1,354 $31.71 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020.
F2 The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F3 The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F4 The options vested with respect to 1/4 of such shares on February 13, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.